awmsg logo



ceftobiprole (Zevtera®)


Reference No. 1641

Publication date:
08/05/2014


Appraisal information

ceftobiprole (Zevtera®) 500 mg powder for concentrate for solution for infusion


Company: Basilea Pharmaceuticals Ltd
BNF category: Infections
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 07/05/2014

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, ceftobiprole (Zevtera®) cannot be endorsed for use within NHS Wales for the treatment of the following infections in adults: hospital-acquired pneumonia, excluding ventilator-associated pneumonia; and community-acquired pneumonia. Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Statement of Advice (SOA)
Download